Europe Enteral Nutrition Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

Europe Enteral Nutrition Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country

  • Report Code : TIPRE00039375
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 126
Buy Now

The Europe enteral nutrition market size is projected to reach US$ 5,797.18 million by 2031 from US$ 3,322.95 million in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. Standardized formulations and plant-based nutrition products are likely to bring in new market trends during the forecast period.

Europe Enteral Nutrition Market Analysis

Gastrointestinal diseases include Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. These diseases often lead to malabsorption of nutrients due to inflammation, damage, or dysfunction of the intestines. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. Research conducted by Crohn's & Colitis UK shows that ~1 in every 123 people in the UK had either Crohn's disease or ulcerative colitis in 2022, accounting for nearly 0.5 million people living with IBD in the UK. According to the study "Tackling the Burden of Digestive Disorders in Europe" published in 2023, over 332 million people are estimated to be living with a digestive disorder in European countries. As per the study, digestive cancers accounted for one-third of the total number of cancer-related deaths among the countries surveyed.

Europe Enteral Nutrition Market Overview

The Europe enteral nutrition market is rapidly expanding with the increasing aging population; rise in chronic diseases such as cancer, diabetes, and neurological disorders (viz., stroke and dementia); and surging awareness of the benefits of enteral nutrition, supported by clinical guidelines. Technological innovations and a growing focus on personalized care are expected to favor the growth of the market in the future.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Europe Enteral Nutrition Market: Strategic Insights

Europe Enteral Nutrition Market
  • Market Size 2023
    US$ 3,322.95 Million
  • Market Size 2031
    US$ 5,797.18 Million

Market Dynamics

GROWTH DRIVERS
  • Increasing Prevalence of Gastrointestinal Diseases
FUTURE TRENDS
  • Standardized Formulations and Plant-Based Nutrition Products
OPPORTUNITIES
  • Strategic Initiatives by Key Market Players

Regional Overview

Regional Overview
  • Europe

Market Segmentation

Market SegmentProduct Type
  • Nasogastric
  • Nasoenteral
  • Sipping
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Enteral Nutrition Market Drivers and Opportunities

Rising Cases of Malnutrition and Premature Births Drive Demand for Enteral Nutrition Formulae and Products

Undernutrition, overweight or obesity, vitamin or mineral deficiency, and poor diet-related noncommunicable diseases are all categorized under malnutrition. The European Society for Clinical Nutrition and Metabolism (ESPEN) and the World Health Organization (WHO) conducted a joint 46th ESPEN Congress in Milan, Italy, in September 2024. The Congress reported that malnutrition affects 30–50% of hospitalized patients, 40% of oncology patients, 30–70% of older adults, 24% of hospitalized cardiovascular or pulmonary disease patients, and 38–78% of patients in intensive care units in Europe. Similarly, as per the "A Multi-Center Survey on Hospital Malnutrition," published in 2021, nearly 11–45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support can be delivered through enteral means, depending on the need, which is an essential and appropriate way of treating most malnutrition cases. Thus, the massive burden of malnutrition in patients from different age groups and the increasing number of premature births drive the demand for enteral nutrition formulae and products in Europe.

Strategic Initiatives by Key Market Players to Create Lucrative Opportunities in Market

Companies operating in the Europe enteral nutrition market continuously focus on strategic developments such as collaborations, expansions, agreements, partnerships, and innovative product formulations. These strategies help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below.

• In May 2024, Danone completed the acquisition of Functional Formularies, a leading whole-food tube feeding business in the US. Through this acquisition, Danone has plans to strengthen its Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges.

• In January 2023, Nutricia launched Fortimel PlantBased Energy, its first plant-based, ready-to-drink oral nutritional supplement. The product is specifically formulated to fulfill the nutritional needs of malnourished populations or people at risk of malnutrition due to illness. Following the launch of Fortimel, the company plans to leverage Danone's (parent company) expertise in plant nutrition to expand its Fortimel portfolio. The new product is available in the Netherlands, Denmark, Norway, Spain, Finland, and the Czech Republic.

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segment that contributed to the derivation of the Europe enteral nutrition market analysis is product type.

  • Based on product type, the Europe enteral nutrition market is segmented into nasogastric, nasoenteral, sipping, and others. The nasogastric segment held the largest share of the market in 2023.

Europe Enteral Nutrition Market Share Analysis by Geography

The Europe enteral nutrition market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and France together are expected to account for a significant market share during the forecast period. Further, Italy, the UK, and Spain are likely to present lucrative opportunities for the market in the coming years. Market growth in Europe is mainly attributed to the increasing geriatric population, rising incidence of chronic diseases and neurological disorders such as stroke and cerebral aneurysms, and product innovations by players operating in the region.

Europe Enteral Nutrition Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3,322.95 Million
Market Size by 2031 US$ 5,797.18 Million
Global CAGR (2023 - 2031) 7.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Nasogastric
  • Nasoenteral
  • Sipping
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Nestlé
  • Danone S.A.
  • Abbott Laboratories
  • Friesland Campina
  • Fresenius SE and Co. KGaA
  • B. Braun SE
  • Dr. Schär AG
  • Arla Food
  • Reckitt Benckiser
  • Perrigo Company PLC
  • Europe Enteral Nutrition Market News and Recent Developments

    The Europe enteral nutrition market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below is a key development witnessed in the Europe enteral nutrition market:

    • Arla Foods Ingredients launched a new whey protein hydrolysate with a better taste profile than comparable ingredients for peptide-based medical nutrition. Lacprodan DI-3092, the highly hydrolyzed whey protein ingredient, presents 10g of high-quality single-source protein packed into 100 ml, which is significantly higher than the market standard of 6–7g per 100 ml. Additionally, it is designed to taste great with minimal bitterness, helping overcome a key challenge in medical nutrition. (Source: Arla Foods Website, November 2024)
    • Kate Farms launched its first Pediatric Blended Meals innovation, bringing to market the first plant-based, organic, whole-food blended meals designed for ease and convenience. Kate Farms Pediatric Blended Meals are designed for children aged 1–13 to help support their healthy growth and development. The formulations can be used for both tube and oral feeding. They are available in three flavors to provide ingredient variety and reflect a typical three-meal day, and feature an innovative reclosable single-serve pouch for quicker and simplified connections to common tube feeding devices. (Source: Kate Farms, Press Release, January 2024)
    • Kate Farms announced the launch of its newest Glucose Support 1.2 shake. As the newest addition to the Kate Farms nutrition portfolio, Glucose Support 1.2 is thoughtfully created to deliver meaningful plant-based nutrition to diabetic patients. This first-of-its-kind plant-based, organic nutrition shake is designed to help manage blood sugar as part of a balanced diet. (Source: Kate Farms, Press Release, February 2022)

    Europe Enteral Nutrition Market Report Coverage and Deliverables

    The "Europe Enteral Nutrition Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Europe enteral nutrition market size and forecast at regional and country levels for all the key market segments covered under the scope
    • Europe enteral nutrition market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Europe enteral nutrition market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Europe enteral nutrition market
    • Detailed company profiles
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are the factors driving the Europe enteral nutrition market growth?

    An increase in the prevalence of chronic disease and a surge in elderly populations are among the significant factors fueling the market growth.

    What are the future trends in the Europe enteral nutrition market?

    Standardized formulations and plant-based nutrition products are likely to emerge as new growth trends in the market in the coming years.

    What would be the estimated value of the Europe enteral nutrition market by 2031?

    The Europe enteral nutrition market value is expected to reach US$ 5,797.18 million by 2031.

    Which are the leading players operating in the Europe enteral nutrition market?

    Nestle SA, Danone SA, Abbott, Fresenius SE & Co KGaA, and B Braun are among the key players operating in the market.

    What would be the expected CAGR of the Europe enteral nutrition market?

    The market is expected to register a CAGR of 7.2% during 2023–2031.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of companies - Europe Enteral Nutrition Market

    • Nestlé
    • Danone S.A.
    • Abbott Laboratories
    • FrieslandCampina
    • Fresenius SE and Co. KGaA
    • B. Braun SE
    • Dr. Schär AG
    • Arla Food
    • Reckitt Benckiser
    • Perrigo Company PLC
    • Fonterra Co-operative Group Limited
    • Kate Farms
    • Nutritional Medicinals, LLC
    Buy Now